CDT Conduit PharmaceuticalsWatchlist
About Conduit Pharmaceuticals Company
Conduit Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of clinical assets to address the unmet medical needs of patients, through exclusive relationships. Its medical needs in the areas of autoimmune disease and idiopathic male infertility. The company is headquartered in San Diego, CA.
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersImpel Pharmaceuticals (NASDAQ:IMPL) shares moved upwards by 141.4% to $0.77 during Thursday's regular session. The market value of their outstanding shares is at $18.4 million. Conduit Pharmace
Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference
SAN DIEGO and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (NASDAQ:CDT) ("Conduit Pharmaceuticals" or "Conduit"), a multi-asset clinical-stage disease-agnostic life science company delivering
KXIN and ICU Among Pre-market Losers